Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Schreiner MediPharm Introduces New Flexi-Cap Prime for Vials | Contract Pharma

Schreiner MediPharm Introduces New Flexi-Cap Prime for Vials

New label-cap combination designed to protect the integrity of original medicine containers

Schreiner MediPharm has developed a new label-cap combination that protects the integrity of original medicine containers, helping to prevent illegal reuse through clear, irreversible first-opening indication.

To help counteract counterfeiters, a special feature of Flexi-Cap Prime is its complex construction, including a tear strip running through both the film cap and the label. When the tear strip is opened at the starter tab, it simultaneously destroys the cap and the label so that undetected reuse of the container is no longer possible.

Flexi-Cap Prime can be integrated into a pharmaceutical manufacturer’s production processes. It is also applied without heat, and can be flexibly adapted to diverse container types, shapes and sizes while the label’s design and the pharma manufacturer’s brand appearance remain unchanged. The integration of additional features, such as counterfeiting protection elements, offers further opportunities for securing the supply chain.
           
For healthcare staff, the Flexi-Cap Prime ensures the integrity of the vial until its final application. Flexi-Cap Prime is easy to use and enables fast and efficient first-opening verification.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters